NCT01319461 - Efficacy and Safety of Intraarticular Injections of Hyalgan in the Treatment of Osteoarthritis of the Knee | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions

Osteoarthritis

Interventions

DEVICE

Hyalgan

Patients will receive intraarticular injection of 20mg /2ml /syringe Hyalgan® once a week for 5 consecutive weeks.

DEVICE

sterile normal saline

Patients will receive intraarticular injection of sterile normal saline once a week for 5 consecutive weeks.

Trial Locations (1)

National taiwan university hospital, Taipei